EP Wealth Advisors LLC Purchases New Shares in Astera Labs, Inc. $ALAB

EP Wealth Advisors LLC acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 4,891 shares of the company's stock, valued at approximately $2,363,000.

Several other institutional investors have also bought and sold shares of ALAB. Rakuten Securities Inc. bought a new stake in shares of Astera Labs in the 2nd quarter worth about $2,700,000. Ieq Capital LLC purchased a new stake in shares of Astera Labs during the 2nd quarter valued at about $695,000. Callan Family Office LLC bought a new position in shares of Astera Labs in the 2nd quarter valued at about $1,367,000. Keating Financial Advisory Services Inc. bought a new position in shares of Astera Labs in the 2nd quarter valued at about $25,000. Finally, Allworth Financial LP bought a new position in shares of Astera Labs in the 2nd quarter valued at about $1,276,000. Institutional investors own 60.47% of the company's stock.

Astera Labs Trading Down 1.9%

Shares of NASDAQ:ALAB opened at $284.97 on Friday. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The company has a market capitalization of $49.44 billion, a price-to-earnings ratio of 141.07 and a beta of 3.84. The firm's 50-day moving average is $352.70 and its 200 day moving average is $244.92.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm's quarterly revenue was up 104.5% compared to the same quarter last year. During the same quarter last year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have weighed in on ALAB. Barclays boosted their price objective on Astera Labs from $200.00 to $325.00 and gave the stock an "equal weight" rating in a research note on Monday, July 20th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Astera Labs in a research note on Tuesday. Rothschild & Co Redburn assumed coverage on Astera Labs in a report on Friday, May 1st. They issued a "neutral" rating and a $153.00 target price for the company. Royal Bank Of Canada boosted their target price on Astera Labs from $425.00 to $500.00 and gave the company an "outperform" rating in a research report on Wednesday, August 5th. Finally, JPMorgan Chase & Co. increased their price target on Astera Labs from $205.00 to $280.00 and gave the company an "overweight" rating in a report on Wednesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $333.00.

Insider Transactions at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of the company's stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer owned 1,266,665 shares of the company's stock, valued at $431,109,432.75. This represents a 6.68% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the sale, the general counsel owned 96,542 shares in the company, valued at approximately $32,872,551. The trade was a 6.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 419,244 shares of company stock valued at $163,135,169. Company insiders own 10.40% of the company's stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source